Launched in Spain and Colombia in 2020, myBIOME is an innovative gut microbiome examination based on technology developed by Microba’s leading researchers in the field of microbiome analysis. The ...
Cinven agreed to buy out Synlab AG for about €1.27 billion ($1.3 billion) two years after listing the German laboratory operator, which has been suffering from reduced demand for its testing ...
FRANKFURT/LONDON (Reuters) - Buyout fund Cinven has launched preparations for a potential stock market listing of German laboratory services group Synlab, while also sounding out potential buyers for ...
EDIT-B™: a reliable, validated and rapid biological response to reduce the diagnostic delay and address an unmet medical need. ALCEDIAG and SYNLAB are making EDIT-B™ , based on RNA editing and AI, ...
MCLEAN, Va.--(BUSINESS WIRE)--Mars, Incorporated (“Mars”) today announced that it has completed its previously announced acquisition of the assets of SYNLAB Vet from SYNLAB Group (FSE: SYAB). SYNLAB ...
(Reuters) – Buyout group BC Partners has put German laboratory operator Synlab up for sale in a potential deal worth more than 1.5 billion euros ($1.6 billion), three people familiar with the matter ...
SYNLAB AG: SYNLAB delivers robust underlying growth in FY 2022 16.03.2023 / 07:00 CET/CEST The issuer is solely responsible for the content of this announcement. SYNLAB delivers robust underlying ...
Buyout fund Cinven has launched preparations for a potential stock market listing of German laboratory services group Synlab, while also sounding out potential buyers for a 5.5 billion euro ($6 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results